🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

62,31 USD

Máx. histórico

108,06

1030 días

Split 1:6 del 25/06/2013

Caída desde máximo

-42,34%

Rango 52 semanas

58,05 – 88,31

Variación hoy

+0,45%

Cierre anterior

62,03

Rango de hoy

62,05 – 64,37

Volumen hoy

1.699.286

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,37%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 20 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/03/2024 65,35 68,35 63,65 63,75 -2,21% 7,19% 2.246.700
15/03/2024 63,43 65,44 62,37 65,19 +2,26% 4,84% 21.706.000
14/03/2024 64,37 64,62 61,33 63,75 -1,36% 5,11% 2.761.400
13/03/2024 65,33 65,80 63,50 64,63 +0,12% 3,52% 2.084.600
12/03/2024 65,00 66,00 62,62 64,55 +0,25% 5,20% 2.384.900
11/03/2024 65,82 66,48 62,16 64,39 -2,07% 6,56% 2.626.700
08/03/2024 67,00 68,38 65,65 65,75 -0,14% 4,07% 1.382.500
07/03/2024 66,88 67,67 65,05 65,84 -1,56% 3,92% 1.590.300
06/03/2024 67,29 68,00 65,40 66,88 +0,68% 3,86% 1.800.400
05/03/2024 66,90 68,15 66,01 66,43 -1,85% 3,20% 2.210.200
04/03/2024 71,03 72,00 66,69 67,68 -8,52% 7,48% 4.175.400
01/03/2024 73,20 75,03 72,53 73,98 +2,41% 3,42% 1.645.400
29/02/2024 73,86 75,00 71,48 72,24 -1,16% 4,77% 1.904.000
28/02/2024 77,94 78,94 69,41 73,09 -9,75% 12,23% 4.376.900
27/02/2024 79,00 81,36 78,60 80,99 +2,52% 3,49% 2.367.500
26/02/2024 77,07 79,93 77,00 79,00 +1,26% 3,80% 1.788.300
23/02/2024 76,00 79,49 75,86 78,02 +3,21% 4,78% 1.738.500
22/02/2024 76,30 77,30 75,52 75,59 -1,19% 2,33% 1.168.700
21/02/2024 76,32 77,35 75,66 76,50 -0,51% 2,21% 974.200
20/02/2024 76,62 78,00 76,01 76,89 +0,00% 2,60% 1.136.300
16/02/2024 78,46 79,59 76,78 76,89 -2,13% 3,58% 1.321.300
15/02/2024 76,82 78,72 76,05 78,56 +2,69% 3,48% 1.704.300
14/02/2024 77,90 78,47 75,59 76,50 -0,69% 3,70% 1.817.200
13/02/2024 77,40 80,99 76,16 77,03 -2,86% 6,24% 2.784.700
12/02/2024 77,40 79,86 76,61 79,30 +3,07% 4,20% 1.345.100
09/02/2024 79,00 79,77 76,52 76,94 -2,53% 4,11% 1.883.800
08/02/2024 77,85 79,39 76,92 78,94 +2,36% 3,17% 1.420.900
07/02/2024 80,23 80,40 77,00 77,12 -3,79% 4,24% 1.427.900
06/02/2024 80,27 80,80 78,05 80,16 +0,00% 3,43% 977.100
05/02/2024 79,23 80,66 76,56 80,16 -2,09% 5,17% 2.665.800